ArticleJournal of thrombosis and haemostasis : JTH2023

Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.

Stéphanie E Reitsma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.